SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (2010 - 2017)

SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (2010 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 SELLAS Life Sciences 1.89 Bn 1.78 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2017 123,000.00
Sep 30, 2017 123,000.00
Jun 30, 2017 148,000.00
Jun 30, 2017 148,000.00
Mar 31, 2017 173,000.00
Mar 31, 2017 173,000.00
Dec 31, 2016 199,000.00
Dec 31, 2016 199,000.00
Sep 30, 2016 226,000.00
Sep 30, 2016 226,000.00
Jun 30, 2016 259,000.00
Jun 30, 2016 259,000.00
Mar 31, 2016 299,000.00
Mar 31, 2016 299,000.00
Dec 31, 2015 335,000.00
Dec 31, 2015 335,000.00
Sep 30, 2015 288,000.00
Sep 30, 2015 288,000.00
Jun 30, 2015 532,000.00
Jun 30, 2015 532,000.00